Prices delayed by at least 15 minutes | Print
Proteome Sciences PLC (PRM)
ORD 1POpen
2.719p
Previous close
2.74p
Trade high
2.98p
Volume
16,420
Year high
5.40p
Year low
2.218p
Dividend yield
–
Market capitalisation
£8.09 mn
P/E ratio
17.43
ISIN
GB0003104196
This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Share price
Company profile
Proteome Sciences PLC is protein biomarker research and development. provider of contract research services for the identification, validation and application of protein biomarkers. Its only reportable segment is the sale of goods and biomarker services. It generates maximum revenue from the TMT product and end customer sales-based royalties. Geographically, it has a presence in the United States, the United Kingdom, the European Union, and Other.
News
Recent trades
Date | Time | Price | Quantity | Value (£) |
---|---|---|---|---|
29/04/2025 | 12:58:45 | 2.98 | 3,355 | 99.98 |
29/04/2025 | 10:43:02 | 2.5048 | 2,500 | 62.62 |
29/04/2025 | 10:19:46 | 2.719 | 10,565 | 287.26 |
28/04/2025 | 04:22:06 | 2.5 | 3,000 | 75.00 |
28/04/2025 | 04:22:06 | 2.98 | 90 | 2.68 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.